Featured Events:

ChinaBio® Partnering Forum 2020
August 25–27, 2020
Delivered Digitally, China Standard Time
Registration is now open!

ChinaBio® Partnering Forum has grown to be the premier life science partnering conference in China since 2009. This year is our 12th anniversary, and for the first time will be delivered digitally! Going virtual will enable participants to hold meetings 24/7 using EBD Group's partneringONE® system, and to see the company presentations, keynote panels and workshops throughout the event. Join us this year for what will prove to be a dynamic and exciting event that will enable you to meet with colleagues from around the world, and to hear from executives, investors and industry experts from leading Chinese and global companies, as well as innovative startups.


Written by Richard Daverman, PhD, Executive Editor, Greg B. Scott.

Recent
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010

Click a link below to view the mailing archive as if it had been sent to you.

2020-06-04 01:30Deep Informatics++ Closes $14 Million Series B for AI-based Pathology Products and more...
2020-06-03 01:30Jiangsu Atom Raises $30 Million to Support Global Trial of Gout Drug and more...
2020-06-02 01:30Nanjing Legend Biotech Plans to Raise $350 Million in US IPO at $2.6 Billion Valuation and more...
2020-05-31 01:30Week in Review: Shenzhen's MGI Tech Raises $1 Billion to Develop Gene Sequencing Machines
2020-05-30 01:30Kintor Pharma Stages $240 Million Hong Kong IPO for Androgen Receptor Drugs and more...
2020-05-29 01:30MGI Tech, a BGI Subsidiary, Raises $1 Billion to Make Gene Sequencing Machines and more...
2020-05-28 01:30Immunochina and EdiGene Team Up to Discover Allogeneic T-Cell Therapies and more...
2020-05-27 01:30Burning Rock of Guangzhou Plans $100 Million IPO on NASDAQ and more...
2020-05-24 01:30Week in Review: CanSino Publishes Positive Data from Trial of COVID-19 Vaccine
2020-05-23 01:30CanSino Publishes Positive Data from COVID-19 Vaccine Trial in The Lancet and more...
2020-05-22 01:30Peijia Medical Raises $302 Million in Hong Kong IPO for Medical Devices and more...
2020-05-21 01:30Zentalis Raises $20 Million for China Subsidiary, Zentera Therapeutics and more...
2020-05-20 01:30Primedicine In-Licenses China Rights to Heart Attack Treatment and more...
2020-05-19 01:30Moderna Reports Early Positive Results in Trial of Coronavirus Vaccine and more...
2020-05-17 01:30Week in Review: Sorrento Announces mAb Inhibits 100% of SARS-CoV-2 Infection
2020-05-16 01:30Sorrento Announces Antibody that Inhibits 100% of SARS-CoV-2 Virus Infection
2020-05-15 01:30Inmagene of Shanghai Partners Affibody's Novel Immunotherapy Candidate and more...
2020-05-14 01:30Zai Lab Approved to Launch Tumor Treating Fields for Glioblastoma in China and more...
2020-05-13 01:30Simcere Acquires China Rights to Novel Stroke Drug from Canadian Biotech and more...
2020-05-12 01:30Nantong Lianya/Novast Raises $140 Million for Generics and Extended-Release Drugs and more...
2020-05-10 01:30Week in Review: Junshi Out-Licenses Ex-China Rights for COVID-19 Therapeutic to Lilly
2020-05-09 01:30Sorrento Forms Triple-Antibody Partnership for Protective COVID-19 Product and more...
2020-05-08 01:30Innovent Reports Positive Results from Phase III NSCLC Trial of PD-1 Drug and more...
2020-05-07 01:30Fosun Partnered mRNA COVID-19 Vaccine Starts US/EU Trials; China Trials to Begin Soon and more...
2020-05-06 01:30Nanjing Immunophage Raises $14 Million for Novel Immune-Regulating Candidates and more...
2020-05-05 01:30Junshi Out-Licenses Ex-China Rights for COVID-19 mAb to Eli Lilly and more...
2020-05-03 01:30Week in Review: I-Mab Seeking $2 Billion Deal for CD-47 Candidate
2020-05-02 01:30Atreca, IGM and BeiGene Partner to Develop Novel SARS-CoV-2 Treatment and more...
2020-05-01 01:30Ocumension Files for Hong Kong IPO to Advance Ophthalmology Portfolio and more...

Please enter all required fields Click to hide
Correct invalid entries Click to hide
 

Subscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

Greg B. Scott
Executive Editor
ChinaBio® Today


ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC